Palmitates

peroxisome proliferator activated receptor gamma ; Mus musculus







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33439102 Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling. 2021 Apr 1 1
2 31654717 Identification of Nogo-B as a new molecular target of peroxisome proliferator-activated receptor gamma. 2020 Jan 2
3 31901728 Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. 2020 Feb 2
4 32232236 Fucoxanthin alleviates palmitate-induced inflammation in RAW 264.7 cells through improving lipid metabolism and attenuating mitochondrial dysfunction. 2020 Apr 30 1
5 32344084 FGF19 alleviates palmitate-induced atrophy in C2C12 cells by inhibiting mitochondrial overload and insulin resistance. 2020 Apr 26 1
6 26941577 Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease. 2016 4
7 27041646 Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells. 2016 Jun 5 1
8 26061913 PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages. 2015 3
9 25431031 Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells. 2014 Dec 2
10 22474127 Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle. 2012 Jun 2
11 20339310 The inhibitory effects of PKCθ on adiponectin expression is mediated by ERK in 3T3-L1 adipocytes. 2011 Jan 2
12 22140527 The multi-level action of fatty acids on adiponectin production by fat cells. 2011 3
13 18303122 JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro. 2008 May 1
14 17387171 CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. 2007 May 25 1